SCHEMBL3689485

SCHEMBL3689485

Cc1nc2ccc(Cl)cn2c1-c1csc(Nc2ccc(C(=O)Nc3ccccc3N)cc2)n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.51
ALDH1A1 P00352 6/20 0.51
MEN1 O00255 5/20 0.51
KMT2A Q03164 5/20 0.51
CFTR P13569 3/20 0.51
CYP1A2 P05177 3/20 0.51
CYP2C19 P33261 3/20 0.51
PRKD3 O94806 1/20 0.50
MAP4K4 O95819 1/20 0.50
PIM1 P11309 1/20 0.50
RPS6KB1 P23443 1/20 0.50
CDK2 P24941 1/20 0.50
FLT4 P35916 1/20 0.50
FLT3 P36888 1/20 0.50
MAPK8 P45983 1/20 0.50
MAPK9 P45984 1/20 0.50
CSNK1D P48730 1/20 0.50
GSK3A P49840 1/20 0.50
GSK3B P49841 1/20 0.50
CSNK2A1 P68400 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12789782 0.92 MAPT (0.55) MAPTALDH1A1MEN1KMT2ACFTR
SCHEMBL12790456 0.90 HDAC1 (0.61) MAPTALDH1A1MEN1KMT2ACFTR
SCHEMBL12790203 0.89 CSNK2A1 (0.49) MAPTALDH1A1MEN1KMT2APRKD3
SCHEMBL3644151 0.89 PRKD3 (0.49) MAPTALDH1A1MEN1KMT2ACFTR
SCHEMBL3683767 0.88 PRKD3 (0.66) MAPTALDH1A1MEN1KMT2ACYP1A2
SCHEMBL12790180 0.88 PRKD3 (0.51) MAPTALDH1A1MEN1KMT2ACFTR
SCHEMBL12790210 0.87 HDAC1 (0.52) MAPTALDH1A1MEN1KMT2APRKD3
SCHEMBL3681184 0.86 HDAC6 (0.57) MAPTALDH1A1MEN1KMT2ACFTR
SCHEMBL12791000 0.85 HDAC1 (0.42) MAPTALDH1A1MEN1KMT2ACYP1A2
SCHEMBL12790445 0.85 HDAC1 (0.47) MAPTALDH1A1MEN1KMT2ACFTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110052527-A1 IMIDAZOPYRIDINYL THIAZOLYL HISTONE DEACETYLASE INHIBITORS GILEAD SCIENCES, INC. (US) 2011-03-03 US disclosed
US-20110052527-A1 IMIDAZOPYRIDINYL THIAZOLYL HISTONE DEACETYLASE INHIBITORS GILEAD SCIENCES, INC. (US) 2011-03-03 US disclosed
US-20110052527-A1 IMIDAZOPYRIDINYL THIAZOLYL HISTONE DEACETYLASE INHIBITORS GILEAD SCIENCES, INC. (US) 2011-03-03 US disclosed
EP-2170882-A1 IMIDAZOPYRIDINYL THIAZOLYL HISTONE DEACETYLASE INHIBITORS Gilead Colorado, Inc. (US) 2010-04-07 EP disclosed
US-20090005374-A1 IMIDAZOPYRIDINYL THIAZOLYL HISTONE DEACETYLASE INHIBITORS GILEAD SCIENCES, INC. 2009-01-01 US disclosed
US-20090005374-A1 IMIDAZOPYRIDINYL THIAZOLYL HISTONE DEACETYLASE INHIBITORS GILEAD SCIENCES, INC. 2009-01-01 US disclosed
US-20090005374-A1 IMIDAZOPYRIDINYL THIAZOLYL HISTONE DEACETYLASE INHIBITORS GILEAD SCIENCES, INC. 2009-01-01 US disclosed
WO-2009002534-A1 IMIDAZOPYRIDINYL THIAZOLYL HISTONE DEACETYLASE INHIBITORS GILEAD COLORADO, INC. (US) 2008-12-31 WO disclosed
WO-2009002534-A1 IMIDAZOPYRIDINYL THIAZOLYL HISTONE DEACETYLASE INHIBITORS GILEAD COLORADO, INC. (US) 2008-12-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090005374-A1 IMIDAZOPYRIDINYL THIAZOLYL HISTONE DEACETYLASE INHIBITORS HDAC1, HDAC8, HDAC5 MAPT 1292/4885ALDH1A1 1787/4885MEN1 3299/4885
US-20110052527-A1 IMIDAZOPYRIDINYL THIAZOLYL HISTONE DEACETYLASE INHIBITORS HDAC1, HDAC8, HDAC5 MAPT 1292/4885ALDH1A1 1787/4885MEN1 3299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.